Clinical Trial Update: IM Ketorolac vs Cambia for the Acute Treatment of Severe Migraine [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update comparing intramuscular ketorolac with Cambia for acute treatment of severe migraine; the current status of the study is not dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Cambia (diclofenac potassium)
• Ketorolac tromethamine (intramuscular) (ketorolac tromethamine)

Snippet

Sponsor: Scripps Health | Conditions: Migraine Headache | Phase 4 | Status: UNKNOWN